Drug Duties in the EU: Agreement Protecting Consumers
- Here's a breakdown of the information from the provided text, focusing on trade disputes and duties:
- * New US Export Limits (2025): The United States has introduced a 15% limit on exports of cars and car components, retroactively starting August 1st.
- In essence, the text describes a complex trade situation where the US has implemented new export limits, the EU believes a prior agreement should be honored, and a...
Here’s a breakdown of the information from the provided text, focusing on trade disputes and duties:
Key Points:
* New US Export Limits (2025): The United States has introduced a 15% limit on exports of cars and car components, retroactively starting August 1st. This limit extends to other sectors (excluding aerospace and generic drugs) starting september 1st.
* EU Response & Agreement: The EU believes a previous agreement with the US “must be respected,” having fulfilled it’s part by submitting a legislative proposal to lower duties on US exports to the EU before the end of August. The EU Commissioner views the agreement as having been meticulously negotiated and as an “insurance policy” against higher tariffs.
* Steel & Aluminum Dispute: A remaining point of contention is the issue of steel and aluminum tariffs. The EU argues its exports of thes materials to the US are limited and specialized.
* EU proposal: The EU plans to send a letter to Washington with a concrete proposal regarding steel and aluminum, highlighting European safeguard measures and concerns about global overcapacity and high rates on derivatives. This is linked to concerns about trade relations with China.
* Switzerland concerns: Switzerland is especially worried about the impact of new US duties on its pharmaceutical industry (“Big Pharma”).
In essence, the text describes a complex trade situation where the US has implemented new export limits, the EU believes a prior agreement should be honored, and a specific dispute remains regarding steel and aluminum.